Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Teyan Pharmaceutical is a Chinese pharmaceutical company specializing in the development, manufacture, and commercialization of traditional Chinese medicines (TCM) and chemical drug preparations. Founded in 1969 as the pharmaceutical factory of the Institute of Specialty Products under the Chinese Academy of Agricultural Sciences, the company was restructured into a limited liability company in 2002. Its product portfolio spans multiple dosage forms, including tablets, hard capsules, granules, and pills, with key commercial products such as Lixin Wan, Naosaitong Wan, and Chuanshouning tablets. The company operates a GMP-compliant manufacturing facility in Jilin City, Jilin Province, focusing on therapeutic areas such as cardiovascular, cerebrovascular, respiratory, and musculoskeletal disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Teyan Pharmaceutical.